[webinar] movedmd trial open-label extension results - october 2017
Published 6 years ago • 674 plays • Length 57:16Download video MP4
Download video MP3
Similar videos
-
![[webinar] movedmd trial: catabasis provides update - february 2017](https://i.ytimg.com/vi/eoiJHVcDuqw/mqdefault.jpg)
39:38
[webinar] movedmd trial: catabasis provides update - february 2017
-
![[webinar] fibrogen update on pamrevlumab & enrolling non-ambulatory study - october 2017](https://i.ytimg.com/vi/lR15r4_SxIU/mqdefault.jpg)
59:30
[webinar] fibrogen update on pamrevlumab & enrolling non-ambulatory study - october 2017
-
59:49
webinar: shield dmd - a bone health study in duchenne (oct 2024)
-
![[webinar] results from phase i/ii hope clinical trial of cap-1002 - april 2017](https://i.ytimg.com/vi/moxUKI0XIuQ/mqdefault.jpg)
59:04
[webinar] results from phase i/ii hope clinical trial of cap-1002 - april 2017
-
15:54
trial update: edasalonexent - catabasis [ppmd's 2017 connect conference}
-
3:56
fda approves first gene therapy for duchenne muscular dystrophy
-
![webinar: sarepta therapeutics - data update from momentum study, srp-5051 [mar 2024]](https://i.ytimg.com/vi/tvnkUnSbSLg/mqdefault.jpg)
45:03
webinar: sarepta therapeutics - data update from momentum study, srp-5051 [mar 2024]
-
44:06
avidity biosciences: presentation and discussion on initial data from explore44 clinical trial
-
![[webinar] polarisdmd: phase 3 clinical trial of edasalonexent, a novel nf-kb inhibitor - nov 2018](https://i.ytimg.com/vi/maoso93phV8/mqdefault.jpg)
47:48
[webinar] polarisdmd: phase 3 clinical trial of edasalonexent, a novel nf-kb inhibitor - nov 2018
-
1:17:47
webinar: capricor data update from ongoing hope-2 open label extension trial (jan 2023)
-
![trial update: mtb-1 - mitobridge [ppmd's 2017 connect conference]](https://i.ytimg.com/vi/leQnKrVm4YI/mqdefault.jpg)
15:42
trial update: mtb-1 - mitobridge [ppmd's 2017 connect conference]
-
46:01
webinar: envision study update with sarepta therapeutics
-
![[webinar] idebenone clinical trials in duchenne - march 2017](https://i.ytimg.com/vi/1hrtoDDncrM/mqdefault.jpg)
52:49
[webinar] idebenone clinical trials in duchenne - march 2017
-
![[webinar] movedmd: a clinical trial of edasalonexent (cat-1004) in duchenne - june 2016](https://i.ytimg.com/vi/v8Zv3W0BQII/mqdefault.jpg)
43:53
[webinar] movedmd: a clinical trial of edasalonexent (cat-1004) in duchenne - june 2016
-
![[webinar] mission dmd: fibrogen’s anti-fibrosis program - february 2017](https://i.ytimg.com/vi/fk9GHdBeLuA/mqdefault.jpg)
41:31
[webinar] mission dmd: fibrogen’s anti-fibrosis program - february 2017
-
54:42
webinar: ataluren update with ptc
-
![[webinar] capricor therapeutics' hope-duchenne clinical trial - november 2017](https://i.ytimg.com/vi/hLNeP-i1vv8/mqdefault.jpg)
50:36
[webinar] capricor therapeutics' hope-duchenne clinical trial - november 2017
-
![[webinar] summit's utrophin modulation program - january 2017](https://i.ytimg.com/vi/PajrkndUgPQ/mqdefault.jpg)
58:18
[webinar] summit's utrophin modulation program - january 2017
-
![eplerenone [ppmd's 2015 connect conference]](https://i.ytimg.com/vi/fTbx2trYN6c/mqdefault.jpg)
20:27
eplerenone [ppmd's 2015 connect conference]
-
![[webinar] positive data from summit's phaseout dmd ezutromid clinical trial - february 2018](https://i.ytimg.com/vi/ttBjxdCbZvI/mqdefault.jpg)
50:28
[webinar] positive data from summit's phaseout dmd ezutromid clinical trial - february 2018